25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AVNS (Avanos) Stock Analysis
Buy, Hold or Sell?

Let's analyze Avanos together

I guess you are interested in Avanos Medical Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Avanos’s Financial Insights
  • 📈 Technical Analysis (TA) – Avanos’s Price Targets

I'm going to help you getting a better view of Avanos Medical Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Avanos Medical Inc

I send you an email if I find something interesting about Avanos Medical Inc.

1. Quick Overview

1.1. Quick analysis of Avanos (30 sec.)










1.2. What can you expect buying and holding a share of Avanos? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
25.0%

What is your share worth?

Current worth
$17.94
Expected worth in 1 year
$9.32
How sure are you?
67.5%

+ What do you gain per year?

Total Gains per Share
$-8.62
Return On Investment
-69.8%

For what price can you sell your share?

Current Price per Share
$12.35
Expected price per share
$11.84 - $13.35
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Avanos (5 min.)




Live pricePrice per Share (EOD)
$12.35
Intrinsic Value Per Share
$5.19 - $38.30
Total Value Per Share
$23.13 - $56.24

2.2. Growth of Avanos (5 min.)




Is Avanos growing?

Current yearPrevious yearGrowGrow %
How rich?$839.4m$1.2b-$200.3m-19.5%

How much money is Avanos making?

Current yearPrevious yearGrowGrow %
Making money-$96.1m-$15.5m-$80.6m-83.8%
Net Profit Margin-53.4%-9.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Avanos (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#40 / 292

Most Revenue
#54 / 292

Most Profit
#286 / 292

Most Efficient
#201 / 292
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Avanos?

Welcome investor! Avanos's management wants to use your money to grow the business. In return you get a share of Avanos.

First you should know what it really means to hold a share of Avanos. And how you can make/lose money.

Speculation

The Price per Share of Avanos is $12.35. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avanos.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avanos, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $17.94. Based on the TTM, the Book Value Change Per Share is $-2.15 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.33 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avanos.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.141.1%-2.08-16.8%-0.33-2.7%-0.73-5.9%-0.46-3.7%-0.40-3.2%
Usd Book Value Change Per Share0.020.2%-2.15-17.4%-0.33-2.7%-0.70-5.6%-0.41-3.3%-0.36-2.9%
Usd Dividend Per Share0.000.0%0.000.0%0.302.4%0.504.1%0.312.5%0.221.8%
Usd Total Gains Per Share0.020.2%-2.15-17.4%-0.03-0.2%-0.19-1.6%-0.10-0.8%-0.14-1.1%
Usd Price Per Share14.33-18.55-22.03-22.35-27.81-34.03-
Price to Earnings Ratio25.40-54.54--74.80--59.26--38.80--12.83-
Price-to-Total Gains Ratio714.37--1,137.70-234.96-12.05--7.96-747.60-
Price to Book Ratio0.80-0.84-0.83-0.88-1.08-1.32-
Price-to-Total Gains Ratio714.37--1,137.70-234.96-12.05--7.96-747.60-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.35
Number of shares80
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.31
Usd Book Value Change Per Share-2.15-0.41
Usd Total Gains Per Share-2.15-0.10
Gains per Quarter (80 shares)-172.33-8.30
Gains per Year (80 shares)-689.34-33.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-689-69999-132-43
20-1379-1388197-264-76
30-2068-2077296-396-109
40-2757-2766395-527-142
50-3447-3455493-659-175
60-4136-4144592-791-208
70-4825-4833691-923-241
80-5515-5522789-1055-274
90-6204-6211888-1187-307
100-6893-6900987-1319-340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%7.05.00.058.3%11.09.00.055.0%25.015.00.062.5%33.017.00.066.0%
Book Value Change Per Share1.03.00.025.0%7.05.00.058.3%11.09.00.055.0%25.015.00.062.5%30.018.02.060.0%
Dividend per Share0.00.04.00.0%4.00.08.033.3%6.00.014.030.0%10.00.030.025.0%12.00.038.024.0%
Total Gains per Share1.03.00.025.0%8.04.00.066.7%12.08.00.060.0%27.013.00.067.5%33.015.02.066.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Avanos Medical Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.020-2.154+10839%-0.329+1741%-0.696+3569%-0.412+2154%-0.361+1899%
Book Value Per Share--17.93622.158-19%26.395-32%25.228-29%25.674-30%25.604-30%
Current Ratio--2.5692.359+9%2.647-3%2.614-2%2.750-7%2.5800%
Debt To Asset Ratio--0.2420.261-7%0.270-10%0.269-10%0.261-7%0.327-26%
Debt To Equity Ratio--0.3200.354-10%0.371-14%0.369-13%0.355-10%0.515-38%
Dividend Per Share----0%0.299-100%0.502-100%0.308-100%0.222-100%
Enterprise Value--499244001.000594610620.250-16%659165010.000-24%708329210.083-30%998590526.050-50%1157885723.275-57%
Eps--0.141-2.080+1575%-0.332+335%-0.726+615%-0.457+424%-0.397+382%
Ev To Ebitda Ratio--5.8324.955+18%11.511-49%10.950-47%11.130-48%43.883-87%
Ev To Sales Ratio--0.7450.864-14%0.969-23%0.969-23%1.359-45%1.413-47%
Free Cash Flow Per Share--0.4060.614-34%0.070+476%0.341+19%0.257+58%0.103+293%
Free Cash Flow To Equity Per Share---0.2160.198-209%-0.321+49%-0.054-75%0.001-42566%-0.219+1%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.797+25%0.898+11%
Intrinsic Value_10Y_max--38.303----------
Intrinsic Value_10Y_min--5.192----------
Intrinsic Value_1Y_max--1.724----------
Intrinsic Value_1Y_min--0.434----------
Intrinsic Value_3Y_max--6.792----------
Intrinsic Value_3Y_min--1.387----------
Intrinsic Value_5Y_max--13.802----------
Intrinsic Value_5Y_min--2.422----------
Market Cap571113400.000-17%670644000.000862235620.000-22%1027115010.000-35%1045012543.333-36%1319730526.000-49%1612683223.250-58%
Net Profit Margin--0.039-0.534+1456%-0.092+334%-0.191+586%-0.121+406%-0.082+309%
Operating Margin--0.070-0.528+850%0.040+75%-0.145+306%-0.094+234%-0.067+195%
Operating Ratio--0.9391.519-38%0.958-2%1.132-17%1.088-14%1.008-7%
Pb Ratio0.689-16%0.7990.838-5%0.835-4%0.883-9%1.077-26%1.325-40%
Pe Ratio21.893-16%25.40354.535-53%-74.800+394%-59.258+333%-38.803+253%-12.834+151%
Price Per Share12.350-16%14.33018.550-23%22.030-35%22.353-36%27.811-48%34.026-58%
Price To Free Cash Flow Ratio7.605-16%8.8249.204-4%-4.130+147%2.045+331%-24.562+378%-46.143+623%
Price To Total Gains Ratio615.661-16%714.367-1137.697+259%234.957+204%12.055+5826%-7.958+101%747.600-4%
Quick Ratio--1.4711.248+18%1.232+19%1.359+8%1.521-3%1.463+1%
Return On Assets--0.006-0.084+1504%-0.009+257%-0.029+586%-0.018+403%-0.013+320%
Return On Equity--0.008-0.117+1584%-0.013+260%-0.040+612%-0.025+418%-0.020+360%
Total Gains Per Share--0.020-2.154+10839%-0.031+252%-0.194+1066%-0.104+617%-0.139+794%
Usd Book Value--839400001.0001029900000.250-18%1230275000.000-32%1178808333.417-29%1214245000.050-31%1211037500.025-31%
Usd Book Value Change Per Share--0.020-2.154+10839%-0.329+1741%-0.696+3569%-0.412+2154%-0.361+1899%
Usd Book Value Per Share--17.93622.158-19%26.395-32%25.228-29%25.674-30%25.604-30%
Usd Dividend Per Share----0%0.299-100%0.502-100%0.308-100%0.222-100%
Usd Enterprise Value--499244001.000594610620.250-16%659165010.000-24%708329210.083-30%998590526.050-50%1157885723.275-57%
Usd Eps--0.141-2.080+1575%-0.332+335%-0.726+615%-0.457+424%-0.397+382%
Usd Free Cash Flow--19000000.00028500000.000-33%3325000.000+471%15941666.667+19%12135000.000+57%4695000.000+305%
Usd Free Cash Flow Per Share--0.4060.614-34%0.070+476%0.341+19%0.257+58%0.103+293%
Usd Free Cash Flow To Equity Per Share---0.2160.198-209%-0.321+49%-0.054-75%0.001-42566%-0.219+1%
Usd Market Cap571113400.000-17%670644000.000862235620.000-22%1027115010.000-35%1045012543.333-36%1319730526.000-49%1612683223.250-58%
Usd Price Per Share12.350-16%14.33018.550-23%22.030-35%22.353-36%27.811-48%34.026-58%
Usd Profit--6600000.000-96150000.000+1557%-15550000.000+336%-33608333.333+609%-21160000.000+421%-18420000.000+379%
Usd Revenue--167500000.000172300000.000-3%170025000.000-1%181966666.667-8%183000000.000-8%214360000.000-22%
Usd Total Gains Per Share--0.020-2.154+10839%-0.031+252%-0.194+1066%-0.104+617%-0.139+794%
 EOD+4 -4MRQTTM+22 -15YOY+23 -163Y+21 -185Y+21 -1910Y+23 -17

3.3 Fundamental Score

Let's check the fundamental score of Avanos Medical Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1521.893
Price to Book Ratio (EOD)Between0-10.689
Net Profit Margin (MRQ)Greater than00.039
Operating Margin (MRQ)Greater than00.070
Quick Ratio (MRQ)Greater than11.471
Current Ratio (MRQ)Greater than12.569
Debt to Asset Ratio (MRQ)Less than10.242
Debt to Equity Ratio (MRQ)Less than10.320
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.006
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Avanos Medical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.209
Ma 20Greater thanMa 5012.318
Ma 50Greater thanMa 10012.479
Ma 100Greater thanMa 20013.469
OpenGreater thanClose12.370
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Avanos Medical Inc

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Fundamental data was last updated by Penke on 2025-06-21 03:16:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Avanos earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • A Net Profit Margin of 3.9% means that $0.04 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avanos Medical Inc:

  • The MRQ is 3.9%. The company is making a profit. +1
  • The TTM is -53.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ3.9%TTM-53.4%+57.4%
TTM-53.4%YOY-9.2%-44.2%
TTM-53.4%5Y-12.1%-41.4%
5Y-12.1%10Y-8.2%-3.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9%-7.2%+11.1%
TTM-53.4%-10.2%-43.2%
YOY-9.2%-11.2%+2.0%
3Y-19.1%-13.1%-6.0%
5Y-12.1%-10.0%-2.1%
10Y-8.2%-9.3%+1.1%
4.3.1.2. Return on Assets

Shows how efficient Avanos is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • 0.6% Return on Assets means that Avanos generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avanos Medical Inc:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -8.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.6%TTM-8.4%+9.0%
TTM-8.4%YOY-0.9%-7.4%
TTM-8.4%5Y-1.8%-6.6%
5Y-1.8%10Y-1.3%-0.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%-2.1%+2.7%
TTM-8.4%-2.3%-6.1%
YOY-0.9%-3.3%+2.4%
3Y-2.9%-2.6%-0.3%
5Y-1.8%-2.6%+0.8%
10Y-1.3%-2.1%+0.8%
4.3.1.3. Return on Equity

Shows how efficient Avanos is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • 0.8% Return on Equity means Avanos generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avanos Medical Inc:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -11.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.8%TTM-11.7%+12.5%
TTM-11.7%YOY-1.3%-10.4%
TTM-11.7%5Y-2.5%-9.2%
5Y-2.5%10Y-2.0%-0.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%-1.8%+2.6%
TTM-11.7%-2.3%-9.4%
YOY-1.3%-3.1%+1.8%
3Y-4.0%-3.7%-0.3%
5Y-2.5%-4.1%+1.6%
10Y-2.0%-5.8%+3.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Avanos Medical Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Avanos is operating .

  • Measures how much profit Avanos makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • An Operating Margin of 7.0% means the company generated $0.07  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avanos Medical Inc:

  • The MRQ is 7.0%. The company is operating less efficient.
  • The TTM is -52.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ7.0%TTM-52.8%+59.9%
TTM-52.8%YOY4.0%-56.8%
TTM-52.8%5Y-9.4%-43.4%
5Y-9.4%10Y-6.7%-2.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0%-10.2%+17.2%
TTM-52.8%-13.6%-39.2%
YOY4.0%-9.9%+13.9%
3Y-14.5%-9.5%-5.0%
5Y-9.4%-9.5%+0.1%
10Y-6.7%-9.4%+2.7%
4.3.2.2. Operating Ratio

Measures how efficient Avanos is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.94 means that the operating costs are $0.94 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avanos Medical Inc:

  • The MRQ is 0.939. The company is less efficient in keeping operating costs low.
  • The TTM is 1.519. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.939TTM1.519-0.581
TTM1.519YOY0.958+0.561
TTM1.5195Y1.088+0.431
5Y1.08810Y1.008+0.080
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9391.392-0.453
TTM1.5191.369+0.150
YOY0.9581.275-0.317
3Y1.1321.337-0.205
5Y1.0881.349-0.261
10Y1.0081.321-0.313
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Avanos Medical Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Avanos is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.57 means the company has $2.57 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avanos Medical Inc:

  • The MRQ is 2.569. The company is able to pay all its short-term debts. +1
  • The TTM is 2.359. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.569TTM2.359+0.209
TTM2.359YOY2.647-0.288
TTM2.3595Y2.750-0.390
5Y2.75010Y2.580+0.170
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5692.510+0.059
TTM2.3592.610-0.251
YOY2.6472.651-0.004
3Y2.6142.949-0.335
5Y2.7503.539-0.789
10Y2.5803.302-0.722
4.4.3.2. Quick Ratio

Measures if Avanos is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • A Quick Ratio of 1.47 means the company can pay off $1.47 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avanos Medical Inc:

  • The MRQ is 1.471. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.248. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.471TTM1.248+0.223
TTM1.248YOY1.232+0.016
TTM1.2485Y1.521-0.273
5Y1.52110Y1.463+0.058
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4711.071+0.400
TTM1.2481.398-0.150
YOY1.2321.652-0.420
3Y1.3591.816-0.457
5Y1.5212.142-0.621
10Y1.4632.350-0.887
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Avanos Medical Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Avanos assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avanos to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.24 means that Avanos assets are financed with 24.2% credit (debt) and the remaining percentage (100% - 24.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avanos Medical Inc:

  • The MRQ is 0.242. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.261. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.242TTM0.261-0.019
TTM0.261YOY0.270-0.009
TTM0.2615Y0.261+0.000
5Y0.26110Y0.327-0.066
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2420.400-0.158
TTM0.2610.413-0.152
YOY0.2700.395-0.125
3Y0.2690.390-0.121
5Y0.2610.414-0.153
10Y0.3270.455-0.128
4.5.4.2. Debt to Equity Ratio

Measures if Avanos is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • A Debt to Equity ratio of 32.0% means that company has $0.32 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avanos Medical Inc:

  • The MRQ is 0.320. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.354. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.320TTM0.354-0.034
TTM0.354YOY0.371-0.017
TTM0.3545Y0.3550.000
5Y0.35510Y0.515-0.161
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3200.554-0.234
TTM0.3540.636-0.282
YOY0.3710.596-0.225
3Y0.3690.638-0.269
5Y0.3550.652-0.297
10Y0.5150.754-0.239
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avanos generates.

  • Above 15 is considered overpriced but always compare Avanos to the Medical Devices industry mean.
  • A PE ratio of 25.40 means the investor is paying $25.40 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avanos Medical Inc:

  • The EOD is 21.893. Based on the earnings, the company is fair priced.
  • The MRQ is 25.403. Based on the earnings, the company is overpriced. -1
  • The TTM is 54.535. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD21.893MRQ25.403-3.510
MRQ25.403TTM54.535-29.132
TTM54.535YOY-74.800+129.335
TTM54.5355Y-38.803+93.338
5Y-38.80310Y-12.834-25.969
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD21.893-1.108+23.001
MRQ25.403-1.439+26.842
TTM54.535-1.120+55.655
YOY-74.800-1.857-72.943
3Y-59.258-1.323-57.935
5Y-38.803-1.482-37.321
10Y-12.834-1.435-11.399
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avanos Medical Inc:

  • The EOD is 7.605. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.824. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 9.204. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.605MRQ8.824-1.219
MRQ8.824TTM9.204-0.380
TTM9.204YOY-4.130+13.334
TTM9.2045Y-24.562+33.766
5Y-24.56210Y-46.143+21.581
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD7.605-2.659+10.264
MRQ8.824-3.262+12.086
TTM9.204-1.554+10.758
YOY-4.130-3.294-0.836
3Y2.045-2.579+4.624
5Y-24.562-2.902-21.660
10Y-46.143-3.379-42.764
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Avanos is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.80 means the investor is paying $0.80 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Avanos Medical Inc:

  • The EOD is 0.689. Based on the equity, the company is cheap. +2
  • The MRQ is 0.799. Based on the equity, the company is cheap. +2
  • The TTM is 0.838. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.689MRQ0.799-0.110
MRQ0.799TTM0.838-0.039
TTM0.838YOY0.835+0.004
TTM0.8385Y1.077-0.238
5Y1.07710Y1.325-0.248
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.6892.005-1.316
MRQ0.7991.989-1.190
TTM0.8382.191-1.353
YOY0.8352.672-1.837
3Y0.8832.695-1.812
5Y1.0773.855-2.778
10Y1.3254.251-2.926
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Avanos Medical Inc.

4.8.1. Institutions holding Avanos Medical Inc

Institutions are holding 96.059% of the shares of Avanos Medical Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc14.91430.00216896968-254859-3.5636
2025-03-31Vanguard Group Inc11.56540.0014534829785190.1595
2025-03-31T. Rowe Price Investment Management,Inc.8.12550.0356375757674626424.782
2025-03-31Dimensional Fund Advisors, Inc.5.61230.00922595353170360.6607
2025-03-31Armistice Capital, LLC4.32490.4295200000020000000
2025-03-31Brown Advisory Holdings Inc4.1760.03961931163260691.3684
2025-03-31State Street Corp4.1720.00111929321-30802-1.5714
2025-03-31Paradice Investment Management LLC2.7814.11671286033237841.8843
2025-03-31Geode Capital Management, LLC2.3280.00121076546354363.4037
2025-03-31Neuberger Berman Group LLC2.25870.01261044533670856.8633
2025-03-31Tributary Capital Management, LLC1.59420.9232737202-155806-17.4473
2025-03-31Morgan Stanley - Brokerage Accounts1.48310.000768584818388436.6329
2025-03-31Charles Schwab Investment Management Inc1.31610.001660863514861932.3074
2025-03-31Millennium Management LLC1.18450.0042547740457703508.3499
2025-03-31Northern Trust Corp1.09250.0011505215-21548-4.0906
2024-12-31D. E. Shaw & Co LP1.06960.005849462714890243.0695
2025-03-31Clark Estates Inc1.0681.49854938804938800
2025-03-31Qube Research & Technologies1.02040.0078471862360071322.093
2025-03-31Pacer Advisors, INC.0.91390.01424226124226120
2025-03-31Prudential Financial Inc0.80720.0099373261-197086-34.5555
Total 71.80767.11633206672+4479763+13.5%

4.9.2. Funds holding Avanos Medical Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-05-31iShares Core S&P Small-Cap ETF5.95470.0451275369300
2025-03-31T. Rowe Price Small-Cap Value4.61990.31992136424656413.1699
2025-04-30Vanguard Total Stock Mkt Idx Inv3.12730.0011144620900
2025-03-31T. Rowe Price U.S. SC Value Eq Tr-D2.70370.3195125029728164929.0765
2025-05-31iShares Russell 2000 ETF2.43450.023112580800
2025-04-30Vanguard Small Cap Index2.38410.00991102503130851.2011
2025-04-30Brown Advisory Small-Cap Fdmtl Val Inv2.35591.1771089482-45297-3.9917
2024-12-31Paradice Global Small Mid Cap Strategy1.83721.7925849576484526.048
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.57520.00972844718140.2496
2025-04-30Vanguard Small Cap Value Index Inv1.53370.017170924622870.3235
2025-04-30DFA US Small Cap Value I1.40340.0579648976-3049-0.4676
2025-05-31Tributary Small Cap Equity1.3371.0239618263-12826-2.0324
2025-04-30Tributary Small Company Instl1.11641.07651627911808129.6538
2025-05-31iShares S&P Small-Cap 600 Value ETF0.97220.09444959500
2025-03-31Fidelity Small Cap Index0.97010.0266448593-725-0.1614
2025-05-31iShares Russell 2000 Value ETF0.87110.047240283500
2025-05-30SPDR® Portfolio S&P 600™ Sm Cap ETF0.83460.044738595300
2025-05-30Pacer US Small Cap Cash Cows 100 ETF0.7330.0995338948-1368-0.402
2025-04-30DFA US Targeted Value I0.72610.035533576342391.2786
2025-04-30Vanguard Tax-Managed Small Cap Adm0.70330.050532523600
Total 38.19346.269917662126+471983+2.7%

5.3. Insider Transactions

Insiders are holding 3.797% of the shares of Avanos Medical Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-03-06Kerr HolbrookSELL700015.25
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,107,800
Total Liabilities268,400
Total Stockholder Equity839,400
 As reported
Total Liabilities 268,400
Total Stockholder Equity+ 839,400
Total Assets = 1,107,800

Assets

Total Assets1,107,800
Total Current Assets352,400
Long-term Assets755,400
Total Current Assets
Cash And Cash Equivalents 97,000
Net Receivables 104,800
Inventory 138,100
Other Current Assets 12,500
Total Current Assets  (as reported)352,400
Total Current Assets  (calculated)352,400
+/-0
Long-term Assets
Property Plant Equipment 141,900
Goodwill 455,900
Intangible Assets 107,200
Long-term Assets Other 25,400
Long-term Assets  (as reported)755,400
Long-term Assets  (calculated)730,400
+/- 25,000

Liabilities & Shareholders' Equity

Total Current Liabilities137,200
Long-term Liabilities131,200
Total Stockholder Equity839,400
Total Current Liabilities
Short-term Debt 19,800
Short Long Term Debt 9,400
Accounts payable 46,000
Other Current Liabilities 54,900
Total Current Liabilities  (as reported)137,200
Total Current Liabilities  (calculated)130,100
+/- 7,100
Long-term Liabilities
Long term Debt 98,000
Capital Lease Obligations 33,500
Long-term Liabilities Other 200
Long-term Liabilities  (as reported)131,200
Long-term Liabilities  (calculated)131,700
+/- 500
Total Stockholder Equity
Common Stock500
Retained Earnings -700,400
Accumulated Other Comprehensive Income -42,300
Other Stockholders Equity 1,581,600
Total Stockholder Equity (as reported)839,400
Total Stockholder Equity (calculated)839,400
+/-0
Other
Capital Stock500
Cash and Short Term Investments 97,000
Common Stock Shares Outstanding 46,800
Liabilities and Stockholders Equity 1,107,800
Net Debt 43,900
Net Invested Capital 946,800
Net Working Capital 215,200
Property Plant and Equipment Gross 282,400
Short Long Term Debt Total 140,900



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
2,534,200
0
0
0
2,484,000
2,463,400
2,456,300
2,449,400
2,527,600
2,536,400
2,485,500
2,006,300
2,000,200
2,019,700
2,112,000
2,095,000
2,071,800
2,086,400
2,124,900
2,148,900
2,195,900
2,202,900
1,917,400
1,844,500
1,833,400
1,834,000
1,783,400
1,807,700
1,799,600
1,763,700
1,755,900
1,799,100
1,672,800
1,648,800
1,683,300
1,597,900
1,594,600
1,766,500
1,752,800
1,775,200
1,786,900
1,734,900
1,666,700
1,724,900
1,692,400
1,661,300
1,657,800
1,656,200
1,154,200
1,107,800
1,107,8001,154,2001,656,2001,657,8001,661,3001,692,4001,724,9001,666,7001,734,9001,786,9001,775,2001,752,8001,766,5001,594,6001,597,9001,683,3001,648,8001,672,8001,799,1001,755,9001,763,7001,799,6001,807,7001,783,4001,834,0001,833,4001,844,5001,917,4002,202,9002,195,9002,148,9002,124,9002,086,4002,071,8002,095,0002,112,0002,019,7002,000,2002,006,3002,485,5002,536,4002,527,6002,449,4002,456,3002,463,4002,484,0000002,534,200
   > Total Current Assets 
0
47,900
0
0
585,100
571,400
598,300
596,100
684,900
703,100
653,100
666,000
676,000
706,600
609,700
605,600
593,500
614,400
654,800
681,000
1,160,700
1,161,100
876,500
737,200
713,600
660,000
572,500
546,500
538,500
524,100
517,100
567,600
467,200
447,900
443,500
405,000
418,600
439,200
437,100
470,000
499,800
453,800
506,900
524,600
487,000
467,800
474,100
472,600
393,400
352,400
352,400393,400472,600474,100467,800487,000524,600506,900453,800499,800470,000437,100439,200418,600405,000443,500447,900467,200567,600517,100524,100538,500546,500572,500660,000713,600737,200876,5001,161,1001,160,700681,000654,800614,400593,500605,600609,700706,600676,000666,000653,100703,100684,900596,100598,300571,400585,1000047,9000
       Cash And Cash Equivalents 
47,900
-47,900
0
0
44,100
35,800
48,500
58,400
149,000
166,200
114,300
112,500
129,500
165,100
79,200
86,700
113,700
143,100
154,800
166,100
219,700
203,100
479,600
411,800
384,500
348,300
288,100
214,400
205,300
187,700
185,000
180,000
111,500
100,100
99,900
97,800
118,500
104,300
106,500
117,000
127,700
95,700
81,800
107,100
87,700
75,800
92,200
89,000
107,700
97,000
97,000107,70089,00092,20075,80087,700107,10081,80095,700127,700117,000106,500104,300118,50097,80099,900100,100111,500180,000185,000187,700205,300214,400288,100348,300384,500411,800479,600203,100219,700166,100154,800143,100113,70086,70079,200165,100129,500112,500114,300166,200149,00058,40048,50035,80044,10000-47,90047,900
       Short-term Investments 
0
95,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000051,5000000000000000000000095,8000
       Net Receivables 
0
0
0
0
203,300
197,900
195,300
192,200
233,900
226,500
200,100
204,400
224,700
206,300
195,200
189,100
190,100
181,200
184,100
194,400
203,000
199,500
189,200
151,800
150,500
135,000
124,300
157,700
163,800
159,600
137,800
182,300
167,900
164,300
165,100
129,100
118,200
161,600
145,400
146,200
167,900
142,700
152,300
145,200
142,800
131,300
123,000
131,900
132,800
104,800
104,800132,800131,900123,000131,300142,800145,200152,300142,700167,900146,200145,400161,600118,200129,100165,100164,300167,900182,300137,800159,600163,800157,700124,300135,000150,500151,800189,200199,500203,000194,400184,100181,200190,100189,100195,200206,300224,700204,400200,100226,500233,900192,200195,300197,900203,3000000
       Other Current Assets 
60,400
0
0
0
52,100
51,900
53,200
50,800
17,600
17,400
14,800
25,500
18,600
26,800
25,000
62,200
17,200
33,400
19,700
20,000
646,900
15,800
48,400
67,600
114,400
94,200
52,400
59,800
47,000
47,400
40,400
42,400
18,900
18,300
18,800
19,700
31,600
31,400
32,400
26,400
13,900
15,400
124,500
115,700
93,300
95,100
95,000
89,800
14,100
12,500
12,50014,10089,80095,00095,10093,300115,700124,50015,40013,90026,40032,40031,40031,60019,70018,80018,30018,90042,40040,40047,40047,00059,80052,40094,200114,40067,60048,40015,800646,90020,00019,70033,40017,20062,20025,00026,80018,60025,50014,80017,40017,60050,80053,20051,90052,10000060,400
   > Long-term Assets 
0
-47,900
0
0
1,898,900
1,892,000
1,858,000
1,853,300
1,842,700
1,833,300
1,832,400
1,340,300
1,324,200
1,313,100
1,502,300
1,489,400
1,478,300
1,472,000
1,470,100
1,467,900
1,035,200
1,041,800
1,040,900
1,107,300
1,119,800
1,174,000
1,210,900
1,261,200
1,261,100
1,239,600
1,238,800
1,231,500
1,205,600
1,200,900
1,239,800
1,192,900
1,176,000
1,327,300
1,315,700
1,305,200
1,287,100
1,281,100
1,159,800
1,200,300
1,205,400
1,193,500
1,183,700
1,183,600
760,800
755,400
755,400760,8001,183,6001,183,7001,193,5001,205,4001,200,3001,159,8001,281,1001,287,1001,305,2001,315,7001,327,3001,176,0001,192,9001,239,8001,200,9001,205,6001,231,5001,238,8001,239,6001,261,1001,261,2001,210,9001,174,0001,119,8001,107,3001,040,9001,041,8001,035,2001,467,9001,470,1001,472,0001,478,3001,489,4001,502,3001,313,1001,324,2001,340,3001,832,4001,833,3001,842,7001,853,3001,858,0001,892,0001,898,90000-47,9000
       Property Plant Equipment 
325,700
0
0
0
324,900
326,000
284,900
292,800
277,800
281,800
286,000
282,100
279,500
275,600
272,600
265,000
260,800
258,300
259,700
261,100
109,900
117,500
123,500
137,000
154,100
214,500
241,600
246,100
248,500
238,600
239,300
233,800
223,600
218,500
214,800
211,100
206,700
203,000
198,200
195,900
194,500
191,800
151,700
143,900
144,000
140,400
140,100
136,000
144,800
141,900
141,900144,800136,000140,100140,400144,000143,900151,700191,800194,500195,900198,200203,000206,700211,100214,800218,500223,600233,800239,300238,600248,500246,100241,600214,500154,100137,000123,500117,500109,900261,100259,700258,300260,800265,000272,600275,600279,500282,100286,000281,800277,800292,800284,900326,000324,900000325,700
       Goodwill 
1,434,100
0
0
0
1,430,100
1,430,800
1,432,800
1,429,000
1,426,100
1,422,100
1,422,800
943,400
945,200
946,800
1,031,600
1,031,900
1,029,000
1,029,700
1,030,900
1,032,000
764,700
764,600
763,800
786,700
783,600
783,700
782,300
800,500
800,900
799,800
800,200
801,200
802,500
802,100
802,600
801,800
801,600
826,000
825,000
823,600
819,400
821,500
762,600
791,500
796,100
794,900
794,400
795,100
455,600
455,900
455,900455,600795,100794,400794,900796,100791,500762,600821,500819,400823,600825,000826,000801,600801,800802,600802,100802,500801,200800,200799,800800,900800,500782,300783,700783,600786,700763,800764,600764,7001,032,0001,030,9001,029,7001,029,0001,031,9001,031,600946,800945,200943,4001,422,8001,422,1001,426,1001,429,0001,432,8001,430,8001,430,1000001,434,100
       Intangible Assets 
1,610,900
0
0
0
141,200
132,500
125,100
116,300
108,300
101,800
95,400
89,000
82,600
77,400
182,400
176,700
169,800
164,400
159,800
154,800
148,900
144,600
139,500
173,900
168,200
163,200
158,500
189,500
184,300
179,300
174,600
170,100
157,700
153,600
149,500
145,300
141,200
271,100
264,900
258,700
251,000
244,700
222,600
242,200
239,500
232,800
226,200
220,100
112,300
107,200
107,200112,300220,100226,200232,800239,500242,200222,600244,700251,000258,700264,900271,100141,200145,300149,500153,600157,700170,100174,600179,300184,300189,500158,500163,200168,200173,900139,500144,600148,900154,800159,800164,400169,800176,700182,40077,40082,60089,00095,400101,800108,300116,300125,100132,500141,2000001,610,900
       Long-term Assets Other 
0
-47,900
0
0
2,700
2,700
15,200
15,200
30,500
27,600
28,200
25,800
2,000
2,000
3,700
3,600
3,600
3,800
3,600
3,700
4,100
3,800
3,500
3,400
7,600
6,400
15,200
12,800
11,300
10,900
10,700
14,400
11,800
11,300
11,000
11,100
16,500
15,900
16,500
16,100
17,600
18,600
18,500
18,400
19,300
19,100
16,700
25,800
23,200
25,400
25,40023,20025,80016,70019,10019,30018,40018,50018,60017,60016,10016,50015,90016,50011,10011,00011,30011,80014,40010,70010,90011,30012,80015,2006,4007,6003,4003,5003,8004,1003,7003,6003,8003,6003,6003,7002,0002,00025,80028,20027,60030,50015,20015,2002,7002,70000-47,9000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
14,900
11,300
12,000
12,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000012,20012,00011,30014,900000000000000
> Total Liabilities 
478,500
0
0
0
404,900
359,900
379,000
370,400
1,036,400
1,024,600
963,700
965,300
944,900
939,900
1,022,500
993,500
969,300
955,500
968,100
968,200
980,500
951,100
630,800
544,300
536,200
553,900
506,500
540,800
534,400
507,200
494,300
509,200
416,300
396,200
387,000
336,000
330,700
510,000
501,200
511,700
495,700
436,200
431,900
502,800
456,100
433,400
435,800
426,500
325,700
268,400
268,400325,700426,500435,800433,400456,100502,800431,900436,200495,700511,700501,200510,000330,700336,000387,000396,200416,300509,200494,300507,200534,400540,800506,500553,900536,200544,300630,800951,100980,500968,200968,100955,500969,300993,5001,022,500939,900944,900965,300963,7001,024,6001,036,400370,400379,000359,900404,900000478,500
   > Total Current Liabilities 
359,100
0
0
0
310,400
265,300
283,800
277,900
356,000
341,000
324,000
326,800
315,200
309,300
304,900
310,700
324,400
310,000
321,800
319,400
389,800
360,600
352,800
265,500
264,300
238,400
187,000
218,100
212,500
189,400
176,000
179,400
166,300
154,600
158,300
129,200
139,200
152,900
151,100
162,300
185,800
158,500
160,500
170,700
234,600
205,200
208,200
212,900
165,900
137,200
137,200165,900212,900208,200205,200234,600170,700160,500158,500185,800162,300151,100152,900139,200129,200158,300154,600166,300179,400176,000189,400212,500218,100187,000238,400264,300265,500352,800360,600389,800319,400321,800310,000324,400310,700304,900309,300315,200326,800324,000341,000356,000277,900283,800265,300310,400000359,100
       Short-term Debt 
0
0
0
0
11,900
9,400
10,400
10,900
3,900
3,900
0
0
578,100
0
0
0
579,000
0
579,900
580,400
39,800
542,000
247,400
0
0
23,400
29,400
29,000
14,700
28,600
30,800
31,200
15,500
30,200
29,800
29,400
14,700
29,000
31,700
33,000
18,200
30,400
33,200
31,600
34,200
20,900
39,000
23,100
20,300
19,800
19,80020,30023,10039,00020,90034,20031,60033,20030,40018,20033,00031,70029,00014,70029,40029,80030,20015,50031,20030,80028,60014,70029,00029,40023,40000247,400542,00039,800580,400579,9000579,000000578,100003,9003,90010,90010,4009,40011,9000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
3,900
0
0
0
578,100
0
0
0
579,000
0
579,900
580,400
39,800
542,000
247,400
0
0
11,700
0
0
0
0
0
0
0
0
0
0
0
0
4,700
6,200
6,200
6,200
6,200
6,200
8,600
9,400
10,200
9,400
9,400
9,400
9,4009,4009,40010,2009,4008,6006,2006,2006,2006,2006,2004,70000000000000011,70000247,400542,00039,800580,400579,9000579,000000578,1000003,90000000000
       Accounts payable 
102,200
0
0
0
118,500
113,500
121,000
118,400
168,700
192,100
200,600
179,100
163,200
181,100
168,600
166,500
173,100
179,700
184,400
172,500
171,200
194,400
176,900
159,200
169,900
148,800
99,400
94,700
83,000
73,500
75,800
75,900
67,600
59,200
65,500
54,900
56,400
63,800
64,200
62,700
67,900
59,600
65,400
52,100
56,300
57,000
51,400
54,200
54,300
46,000
46,00054,30054,20051,40057,00056,30052,10065,40059,60067,90062,70064,20063,80056,40054,90065,50059,20067,60075,90075,80073,50083,00094,70099,400148,800169,900159,200176,900194,400171,200172,500184,400179,700173,100166,500168,600181,100163,200179,100200,600192,100168,700118,400121,000113,500118,500000102,200
       Other Current Liabilities 
160,300
0
0
0
155,600
120,000
128,600
142,600
160,000
121,200
110,800
132,300
152,000
117,500
127,200
137,200
151,300
121,300
137,400
146,900
172,000
166,200
175,900
89,300
87,900
62,300
54,000
90,600
111,600
84,000
65,000
70,300
80,500
61,800
61,000
43,100
65,100
57,400
50,000
57,100
78,500
47,700
56,100
77,000
127,400
92,300
111,700
129,400
73,300
54,900
54,90073,300129,400111,70092,300127,40077,00056,10047,70078,50057,10050,00057,40065,10043,10061,00061,80080,50070,30065,00084,000111,60090,60054,00062,30087,90089,300175,900166,200172,000146,900137,400121,300151,300137,200127,200117,500152,000132,300110,800121,200160,000142,600128,600120,000155,600000160,300
   > Long-term Liabilities 
0
0
0
0
94,500
94,600
95,200
92,500
680,400
683,600
639,700
638,500
629,700
630,600
717,600
682,800
644,900
645,500
646,300
648,800
590,700
590,500
278,000
278,800
271,900
315,500
319,500
322,700
321,900
317,800
318,300
329,800
250,000
241,600
228,700
206,800
191,500
357,100
350,100
349,400
309,900
277,700
271,400
332,100
221,500
228,200
227,600
213,600
159,800
131,200
131,200159,800213,600227,600228,200221,500332,100271,400277,700309,900349,400350,100357,100191,500206,800228,700241,600250,000329,800318,300317,800321,900322,700319,500315,500271,900278,800278,000590,500590,700648,800646,300645,500644,900682,800717,600630,600629,700638,500639,700683,600680,40092,50095,20094,60094,5000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
632,300
631,400
585,800
585,900
578,100
578,500
624,000
589,400
579,000
579,400
579,900
580,400
541,100
542,000
247,400
247,600
247,700
247,900
247,800
247,900
248,100
248,200
248,400
248,500
180,000
175,000
165,000
145,000
130,000
254,400
249,300
247,800
226,300
204,700
0
0
0
0
0
0
0
0
00000000204,700226,300247,800249,300254,400130,000145,000165,000175,000180,000248,500248,400248,200248,100247,900247,800247,900247,700247,600247,400542,000541,100580,400579,900579,400579,000589,400624,000578,500578,100585,900585,800631,400632,30000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-11,900
-9,400
-10,400
-10,900
-3,900
-3,900
0
0
-578,100
0
0
0
-579,000
0
-579,900
-580,400
-39,800
-542,000
-247,400
0
0
46,000
50,800
48,000
62,600
44,500
43,500
40,500
53,300
35,000
32,600
31,400
42,800
25,500
20,200
17,200
29,300
14,100
11,200
10,600
6,900
17,200
4,200
17,100
15,200
13,700
13,70015,20017,1004,20017,2006,90010,60011,20014,10029,30017,20020,20025,50042,80031,40032,60035,00053,30040,50043,50044,50062,60048,00050,80046,00000-247,400-542,000-39,800-580,400-579,9000-579,000000-578,10000-3,900-3,900-10,900-10,400-9,400-11,9000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
14,900
11,300
12,000
12,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000012,20012,00011,30014,900000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
48,100
0
0
0
27,800
28,200
30,200
30,000
30,100
29,900
30,000
31,900
31,800
30,200
29,600
30,100
19,800
63,200
71,100
74,300
73,800
69,600
69,900
67,500
64,300
61,000
4,900
56,200
51,900
68,000
23,500
64,600
18,700
15,500
15,400
15,600
4,100
4,100
3,900
3,900
200
200
2002003,9003,9004,1004,10015,60015,40015,50018,70064,60023,50068,00051,90056,2004,90061,00064,30067,50069,90069,60073,80074,30071,10063,20019,80030,10029,60030,20031,80031,90030,00029,90030,10030,00030,20028,20027,80000048,10000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
23,800
23,900
63,400
63,400
35,800
36,200
36,400
36,500
17,800
18,300
1,000
1,100
4,400
4,400
600
500
0
0
0
13,800
5,700
5,600
5,600
5,600
9,600
34,700
34,700
37,000
25,400
25,100
21,800
0
0
0
0
0
0
0
000000021,80025,10025,40037,00034,70034,7009,6005,6005,6005,6005,70013,8000005006004,4004,4001,1001,00018,30017,80036,50036,40036,20035,80063,40063,40023,90023,800000000000000
> Total Stockholder Equity
2,055,700
2,055,700
0
0
2,079,100
2,103,500
2,077,300
2,079,000
1,491,200
1,511,800
1,521,800
1,041,000
1,055,300
1,079,800
1,089,500
1,101,500
1,102,500
1,130,900
1,156,800
1,180,700
1,215,400
1,251,800
1,286,600
1,300,200
1,297,200
1,280,100
1,276,900
1,266,900
1,265,200
1,256,500
1,261,600
1,289,900
1,256,500
1,252,600
1,296,300
1,261,900
1,263,900
1,256,500
1,251,600
1,263,500
1,291,200
1,298,700
1,234,800
1,222,100
1,236,300
1,227,900
1,222,000
1,229,700
828,500
839,400
839,400828,5001,229,7001,222,0001,227,9001,236,3001,222,1001,234,8001,298,7001,291,2001,263,5001,251,6001,256,5001,263,9001,261,9001,296,3001,252,6001,256,5001,289,9001,261,6001,256,5001,265,2001,266,9001,276,9001,280,1001,297,2001,300,2001,286,6001,251,8001,215,4001,180,7001,156,8001,130,9001,102,5001,101,5001,089,5001,079,8001,055,3001,041,0001,521,8001,511,8001,491,2002,079,0002,077,3002,103,5002,079,100002,055,7002,055,700
   Common Stock
0
0
0
0
2,098,700
2,118,100
2,088,900
2,100,100
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
5005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005005002,100,1002,088,9002,118,1002,098,7000000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
7,300
29,000
36,900
-433,600
-419,000
-404,800
-398,300
-389,200
-379,200
-366,400
-349,300
-332,700
-299,900
-279,700
-244,400
-240,200
-242,400
-262,700
-270,700
-282,200
-288,300
-284,600
-287,600
-268,300
-315,500
-323,100
-285,200
-320,300
-310,300
-304,500
-293,100
-270,000
-253,100
-253,600
-321,700
0
0
0
0
0
0
0
0000000-321,700-253,600-253,100-270,000-293,100-304,500-310,300-320,300-285,200-323,100-315,500-268,300-287,600-284,600-288,300-282,200-270,700-262,700-242,400-240,200-244,400-279,700-299,900-332,700-349,300-366,400-379,200-389,200-398,300-404,800-419,000-433,60036,90029,0007,30000000000
   Accumulated Other Comprehensive Income 
0
2,055,700
0
0
-19,600
-14,600
-11,600
-21,100
-19,100
-25,600
-28,900
-42,800
-43,200
-36,600
-38,100
-38,300
-50,100
-39,400
-34,300
-30,600
-31,300
-21,800
-32,100
-30,500
-33,700
-33,000
-31,100
-34,800
-32,000
-46,900
-42,000
-37,100
-28,100
-32,300
-30,000
-33,600
-33,800
-32,100
-37,800
-42,900
-35,800
-35,800
-28,400
-33,000
-27,000
-29,500
-37,500
-36,900
-44,600
-42,300
-42,300-44,600-36,900-37,500-29,500-27,000-33,000-28,400-35,800-35,800-42,900-37,800-32,100-33,800-33,600-30,000-32,300-28,100-37,100-42,000-46,900-32,000-34,800-31,100-33,000-33,700-30,500-32,100-21,800-31,300-30,600-34,300-39,400-50,100-38,300-38,100-36,600-43,200-42,800-28,900-25,600-19,100-21,100-11,600-14,600-19,600002,055,7000
   Capital Surplus 
0
0
0
0
0
0
0
0
1,502,500
1,507,900
1,514,300
1,517,900
1,518,000
1,521,700
1,527,300
1,530,400
1,533,200
1,538,100
1,543,800
1,547,400
1,550,500
1,557,300
1,567,700
1,575,500
1,578,100
1,582,500
1,586,800
1,592,100
1,593,900
1,596,400
1,599,900
1,604,100
1,609,400
1,617,300
1,621,300
1,625,700
1,628,800
1,633,300
1,637,400
1,642,300
1,646,400
1,651,000
1,654,900
0
0
0
0
0
0
0
00000001,654,9001,651,0001,646,4001,642,3001,637,4001,633,3001,628,8001,625,7001,621,3001,617,3001,609,4001,604,1001,599,9001,596,4001,593,9001,592,1001,586,8001,582,5001,578,1001,575,5001,567,7001,557,3001,550,5001,547,4001,543,8001,538,1001,533,2001,530,4001,527,3001,521,7001,518,0001,517,9001,514,3001,507,9001,502,50000000000
   Treasury Stock000000000000-40,700-21,300-10,400-10,300-9,800-9,800-9,300-9,200-8,900-8,900-8,700-8,600-7,200-5,300-5,100-5,100-4,500-4,400-3,900-3,900-1,900-1,900-1,900-1,900-1,000-1,000-1,000-1,0000000000000
   Other Stockholders Equity 
0
0
0
0
2,098,700
0
0
2,100,100
1,502,500
1,507,900
1,513,300
1,516,900
1,517,000
1,520,700
1,525,400
1,528,500
1,531,300
1,536,200
1,539,900
1,543,500
1,546,100
1,552,800
1,562,600
1,570,400
1,572,800
1,575,300
1,578,200
1,583,400
1,585,000
1,587,500
1,590,700
1,594,800
1,599,600
1,607,500
1,611,000
1,615,300
1,607,500
1,592,600
1,582,000
1,575,900
1,579,600
1,583,100
1,584,400
1,580,000
1,577,700
1,572,700
1,573,000
1,575,800
1,579,600
1,581,600
1,581,6001,579,6001,575,8001,573,0001,572,7001,577,7001,580,0001,584,4001,583,1001,579,6001,575,9001,582,0001,592,6001,607,5001,615,3001,611,0001,607,5001,599,6001,594,8001,590,7001,587,5001,585,0001,583,4001,578,2001,575,3001,572,8001,570,4001,562,6001,552,8001,546,1001,543,5001,539,9001,536,2001,531,3001,528,5001,525,4001,520,7001,517,0001,516,9001,513,3001,507,9001,502,5002,100,100002,098,7000000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue687,800
Cost of Revenue-306,500
Gross Profit381,300381,300
 
Operating Income (+$)
Gross Profit381,300
Operating Expense-777,500
Operating Income-396,200-396,200
 
Operating Expense (+$)
Research Development26,200
Selling General Administrative318,500
Selling And Marketing Expenses0
Operating Expense777,500344,700
 
Net Interest Income (+$)
Interest Income5,100
Interest Expense-12,200
Other Finance Cost-0
Net Interest Income-7,100
 
Pretax Income (+$)
Operating Income-396,200
Net Interest Income-7,100
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-403,300-389,100
EBIT - interestExpense = -403,300
-409,100
-379,900
Interest Expense12,200
Earnings Before Interest and Taxes (EBIT)-391,100-391,100
Earnings Before Interest and Taxes (EBITDA)-345,600
 
After tax Income (+$)
Income Before Tax-403,300
Tax Provision--17,000
Net Income From Continuing Ops-386,300-386,300
Net Income-392,100
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,084,000
Total Other Income/Expenses Net-7,1007,100
 

Technical Analysis of Avanos
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Avanos. The general trend of Avanos is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Avanos's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Avanos Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Avanos Medical Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 13.04 < 13.31 < 13.35.

The bearish price targets are: 12.03 > 11.90 > 11.84.

Know someone who trades $AVNS? Share this with them.👇

Avanos Medical Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Avanos Medical Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Avanos Medical Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Avanos Medical Inc. The current macd is -0.06175177.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Avanos price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Avanos. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Avanos price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Avanos Medical Inc Daily Moving Average Convergence/Divergence (MACD) ChartAvanos Medical Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Avanos Medical Inc. The current adx is 12.62.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Avanos shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Avanos Medical Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Avanos Medical Inc. The current sar is 11.79.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Avanos Medical Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Avanos Medical Inc. The current rsi is 49.21. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Avanos Medical Inc Daily Relative Strength Index (RSI) ChartAvanos Medical Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Avanos Medical Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Avanos price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Avanos Medical Inc Daily Stochastic Oscillator ChartAvanos Medical Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Avanos Medical Inc. The current cci is 17.05.

Avanos Medical Inc Daily Commodity Channel Index (CCI) ChartAvanos Medical Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Avanos Medical Inc. The current cmo is 2.06480977.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Avanos Medical Inc Daily Chande Momentum Oscillator (CMO) ChartAvanos Medical Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Avanos Medical Inc. The current willr is -44.35169727.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Avanos is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Avanos Medical Inc Daily Williams %R ChartAvanos Medical Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Avanos Medical Inc.

Avanos Medical Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Avanos Medical Inc. The current atr is 0.35609611.

Avanos Medical Inc Daily Average True Range (ATR) ChartAvanos Medical Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Avanos Medical Inc. The current obv is -2,229,234.

Avanos Medical Inc Daily On-Balance Volume (OBV) ChartAvanos Medical Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Avanos Medical Inc. The current mfi is 27.17.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Avanos Medical Inc Daily Money Flow Index (MFI) ChartAvanos Medical Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Avanos Medical Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Avanos Medical Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Avanos Medical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.209
Ma 20Greater thanMa 5012.318
Ma 50Greater thanMa 10012.479
Ma 100Greater thanMa 20013.469
OpenGreater thanClose12.370
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Avanos with someone you think should read this too:
  • Are you bullish or bearish on Avanos? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Avanos? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Avanos Medical Inc

I send you an email if I find something interesting about Avanos Medical Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Avanos Medical Inc.

Receive notifications about Avanos Medical Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.